Dermatol. praxi. 2019;13(2):80-82 | DOI: 10.36290/der.2019.013

Severe form of atopic dermatitis – candidate for dupilumab therapy

doc. MUDr. Spyridon Gkalpakiotis, Ph.D, MBA, MUDr. Milena Tánczosová
Dermatovenerologická klinika 3. LF UK a FNKV, Praha

Atopic dermatitis is a chronic inflammatory skin disease affecting between 1 and 3 % of adult population. The incidence in children is
even higher. Due to significant itching, other subjective problems, and also the visibility of the lesions significantly reduces the quality
of life. In localized forms, topical therapies are often sufficient, but systemic therapy is needed in generalized settings. Here we describe
the case of a patient with severe atopic dermatitis who has failed classical systemic therapy and is a suitable candidate for biologic
treatment with dupilumab.

Keywords: atopic dermatitis, systemic therapy, dupilumab

Published: June 10, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gkalpakiotis S, Tánczosová M. Severe form of atopic dermatitis – candidate for dupilumab therapy. Dermatol. praxi. 2019;13(2):80-82. doi: 10.36290/der.2019.013.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Nutten, S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann Nutr Metab. 2015; 66 Suppl 1: 8-16. Go to original source... Go to PubMed...
    2. Štork J. Dermatovenerologie. 2. vyd. Praha: Galén, c2013: 162-165.
    3. Wollenberg A, Barbarot S, Bieber T. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018 May; 32(5): 657-682. Go to original source... Go to PubMed...
    4. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018 Jun; 32(6): 850-878. Go to original source... Go to PubMed...
    5. Seegräber M, Srour J, Walter A, et al. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol. 2018 May; 11(5): 467-474. Go to original source... Go to PubMed...
    6. Simpson EL, Bieber T, Guttman-Yassky E. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016 Dec 15; 375(24): 2335-2348. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.